Sacral Neuromodulation in Non-Obstructive Urinary Retention and Painful Bladder Syndrome: an Update

详细信息    查看全文

• 作者：Nathan Hoag ; Johan Gani
• 关键词：Neuromodulation ; Sacral nerve stimulation ; Urinary retention ; Cystitis ; Interstitial ; Pelvic pain ; Voiding dysfunction
• 刊名：Current Bladder Dysfunction Reports
• 出版年：2015
• 出版时间：September 2015
• 年：2015
• 卷：10
• 期：3
• 页码：303-307
• 全文大小：250 KB
• 参考文献：Papers of particular interest, published recently, have been highlighted as: 鈥?Of importance1.Schmidt RA, Bruschini H, Tanagho EA. Sacral root stimulation in controlled micturition. Peripheral somatic neurotomy and voiding. Invest Urol. 1979;17:130鈥?.PubMed
  2.Chartier-Kastler E. Sacral neuromodulation for treating the symptoms of overactive bladder syndrome and non-obstructive urinary retention: >10聽years of clinical experience. BJU Int. 2008;101:417鈥?3.CrossRef PubMed
  3.Gupta P, Ehlert MJ, Sirls LT, et al. Percutaneous tibial nerve stimulation and sacral neuromodulation: an update. Curr Urol Rep. 2015;16:1鈥?.CrossRef
  4.Vasavada SP, Rackley RR. Electrical stimulation and neuromodulation in storage and emptying failure. In: Kavoussi LR, Partin AW, Novick AC, et al., editors. Campbell-Walsh Urology, Vol 3. 10th ed. Philadelphia: Saunders; 2012. Chap 70.
  5.Spinelli M, Weil E, Ostardo E, et al. New tined lead electrode in sacral neuromodulation: experience from a multicenter European study. World J Urol. 2005;23:225鈥?.CrossRef PubMed
  6.Leong RK, De Wachter SGG, Nieman FHM, et al. PNE versus 1st stage tined lead procedure: a direct comparaison to select the most sensitive test method to identify patients suitable for sacral neuromodulation therapy. Neurourol Urodyn. 2011;30:1249鈥?2.PubMed
  7.Spinelli M, Giardiello G, Gerber M, et al. New sacral neuromodulation lead for percutaneous implantation using local anesthesia: description and first experience. J Urol. 2003;170:1905鈥?.CrossRef PubMed
  8.Comiter CV. Sacral nerve stimulation to treat nonobstructive urinary retention in women. Curr Urol Rep. 2008;9:405鈥?1.CrossRef PubMed
  9.Fowler CJ, Christmas TJ, Chapple CR, et al. Abnormal electromyographic activity of the urethral sphincter, voiding dysfunction, and polycystic ovaries: a new syndrome? Br Med J. 1988;297:1436鈥?.CrossRef
  10.Jonas U, Fowler CJ, Chancellor MB, et al. Efficacy of sacral nerve stimulation for urinary retention: results 18聽months after implantation. J Urol. 2001;165:15鈥?.CrossRef PubMed
  11.Hassouna M, Shaker HS. Sacral root neuromodulation in idiopathic nonobstructive chronic urinary retention. J Urol. 1998;159:1476鈥?.CrossRef PubMed
  12.DasGupta R, Fowler CJ. The management of female voiding dysfunction: Fowler鈥檚 syndrome鈥攁 contemporary update. Curr Opin Urol. 2003;13:293.CrossRef PubMed
  13.DasGupta R, Critchley HD, Dolan RJ, et al. Changes in brain activity following sacral neuromodulation for urinary retention. J Urol. 2005;174:2268鈥?2.CrossRef PubMed
  14.Gross C, Habli M, Lindsell C, et al. Sacral neuromodulation for nonobstructive urinary retention: a meta-analysis. Female Pelvic Med Reconstr Surg. 2010;16:249鈥?3.CrossRef PubMed
  15.鈥?/div>Peeters K, Sahai A, De Ridder D, et al. Long-term follow-up of sacral neuromodulation for lower urinary tract dysfunction. BJU Int. 2014;113:789鈥?4. Retrospective review presenting long-term follow-up data on SNM for non-obstructive urinary retention. Success rate (>50聽% reduction in ISC) was seen in 73聽%, while cure (100聽% reduction in ISC) was seen in 62.5聽% and 53聽% for Fowler鈥檚 syndrome, and idiopathic urinary retention, respectively.CrossRef PubMed
  16.鈥?/div>Al-Zahrani AA, Elzayat EA, Gajewski JB. Long-term outcome and surgical interventions after sacral neuromodulation implant for lower urinary tract symptoms: 14-year experience at 1 center. J Urol. 2011;185:981鈥?. Long-term review of patients undergoing SNM for voiding dysfunction. Demonstrated that in 16 patients with SNM implantation, an 87.5聽% success was obtained.CrossRef PubMed
  17.鈥?/div>Saber-Khalaf M, Abtahi B, Gonzales G, et al. Sacral neuromodulation outcomes in male patients with chronic urinary retention. Neuromodulation. 2015. doi:10.鈥?111/鈥媙er.鈥?2268 . Review of results of SNM in males with chronic urinary retention that demonstrated an overall 66.7聽% success rate.PubMed
  18.Hanno P, Dmochowski R. Status of international consensus on interstitial cystitis/bladder pain syndrome/painful bladder syndrome: 2008 snapshot. Neurourol Urodyn. 2009;28:274.CrossRef PubMed
  19.Hanno PM, Burks DA, Clemens JQ, et al. AUA guideline for the diagnosis and treatment of interstitial cystitis/bladder pain syndrome. J Urol. 2011;185:2162鈥?0.CrossRef PubMed
  20.Zabihi N, Mourtzinos A, Maher MG, et al. Short-term results of bilateral S2-S4 sacral neuromodulation for the treatment of painful baldder syndrome, and chronic pelvic pain. Int Urogynecol J. 2008;19:553鈥?.CrossRef
  21.Moldwin RM, Evans RJ, Stanford EJ, et al. Rational approaches to the treatment of patients with interstitial cystitis. J Urol. 2007;69:73鈥?1.CrossRef
  22.Banakhar MA, Al-Shaiji TF, Hassouna M. Sacral neuromodulation in the treatment of interstitial cystitis/painful bladder syndrome: should it be off label? Curr Bladder Dys Rep. 2012;7:120鈥?.CrossRef
  23.Bemelmans BL, Mundy AR, Craggs MD. Neuromodulation by implant for treating lower urinary tract symptoms and dysfunction. Eur Urol. 1999;36:81鈥?1.CrossRef PubMed
  24.Peters KM, Carey JM, Konstandt DB. Sacral neuromodulation for the treatment of refractory interstitial cystitis: outcomes based on technique. Int Urogynecol J Pelvic Floor Dysfunct. 2003;14:223鈥?.CrossRef PubMed
  25.Comiter C. Sacral neuromodulation for the symptomatic treatment of refractory interstitial cystitis: a prospective study. J Urol. 2003;169:1369鈥?3.CrossRef PubMed
  26.Powell CR, Kreder KJ. Long-term outcomes of urgency-frequency syndrome due to painful bladder syndrome treated with sacral neuromodulation and analysis of failures. J Urol. 2010;183:173鈥?.CrossRef PubMed
  27.鈥?/div>Gakewski JB, Al-Zahrani AA. The long-term efficacy of sacral neuromodulation in the management of intractable cases of bladder pain syndrome: 14聽years of experience in one centre. BJU Int. 2011;107:1258鈥?4. Single centre, 14 year experience with SNM for PBS demonstrating a 72聽% long-term success rate, but 50聽% revision rate.CrossRef
  28.鈥?/div>Marinkovic SP, Gillen LM, Marinkovic CM. Minimum 6-year outcomes for interstitial cystitis treated with sacral neuromodulation. Int Urogynecol J. 2011;22:407鈥?2. Long-term follow up of IC patients treated with SNM showing significantly improved pelvic pain/urgency and visual analog pain scores, with mean follow-up of 86聽months.CrossRef PubMed
  29.Pham K, Guralnick ML, O鈥機onnor RC. Unilateral versus bilateral stage I neuromodulator treatment of refractory voiding dysfunction. Neurourol Urodyn. 2008;27:779鈥?1.CrossRef PubMed
  30.Marcelissen TA, Leong RK, Serroyen J, et al. The use of bilateral sacral nerve stimulation in patients with loss of unilateral treatment efficacy. J Urol. 2011;185:976鈥?0.CrossRef PubMed
  31.Scheepens WA, de Bie RA, Weil EHJ, et al. Unilateral versus bilateral sacral neuromodulation in patients with chronic voiding dysfunction. J Urol. 2002;168:2046鈥?0.CrossRef PubMed
  
• 作者单位：Nathan Hoag (1)
  Johan Gani (1)
  
  1. Austin Hospital, 145 Studley Rd, Heidelberg, Victoria, 3084, Australia
  
• 刊物主题：Urology/Andrology;
• 出版者：Springer US
• ISSN：1931-7220

文摘

Sacral neuromodulation (SNM) is an established treatment option for several urologic conditions, and its use continues to grow. Indications and applications for SNM are expanding as our understanding of its mechanism of action improves, and our experience develops. Current urologic applications include overactive bladder (OAB), non-obstructive urinary retention, and pelvic pain disorders. SNM has become an established therapeutic modality for non-obstructive urinary retention, while SNM for pelvic pain disorders has found a place in accepted treatment guidelines. This review provides an update on SNM and focuses on developments in SNM relating to the less-studied applications of non-obstructive urinary retention and painful bladder syndrome. Keywords Neuromodulation Sacral nerve stimulation Urinary retention Cystitis Interstitial Pelvic pain Voiding dysfunction